Fifty-five new apprentices, including 15 from London, have joined UK Power Networks’ £6m training programme to support Britain’s clean ...
New research led by Mass General Brigham followed more than 3,500 patients, finding that 10.3% had symptoms consistent with ...
Company AnnouncementEPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback